Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

Similar articles for PubMed (Select 20380657)

1.

Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots.

Fischer M, Timper K, Radimerski T, Dembinski K, Frey DM, Zulewski H, Keller U, Müller B, Christ-Crain M, Grisouard J.

Diabetes Obes Metab. 2010 Apr;12(4):356-9. doi: 10.1111/j.1463-1326.2009.01169.x.

PMID:
20380657
2.

Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.

Bauer S, Weigert J, Neumeier M, Wanninger J, Schäffler A, Luchner A, Schnitzbauer AA, Aslanidis C, Buechler C.

Arch Med Res. 2010 Feb;41(2):75-82. doi: 10.1016/j.arcmed.2010.02.010. Epub 2010 Mar 27.

PMID:
20470935
3.

Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women.

Marette A, Mauriège P, Marcotte B, Atgié C, Bouchard C, Thériault G, Bukowiecki LJ, Marceau P, Biron S, Nadeau A, Després JP.

Diabetologia. 1997 May;40(5):590-8.

PMID:
9165229
4.

Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.

Virtanen KA, Hällsten K, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Knuuti J, Huupponen R, Lönnroth P, Nuutila P.

Diabetes. 2003 Feb;52(2):283-90.

5.
6.

Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes.

Sauma L, Franck N, Paulsson JF, Westermark GT, Kjølhede P, Strålfors P, Söderström M, Nystrom FH.

Diabetologia. 2007 Jan;50(1):195-201. Epub 2006 Nov 15.

PMID:
17106695
7.

Site-specific differences of insulin action in adipose tissue derived from normal prepubertal children.

Grohmann M, Stewart C, Welsh G, Hunt L, Tavaré J, Holly J, Shield J, Sabin M, Crowne E.

Exp Cell Res. 2005 Aug 15;308(2):469-78.

PMID:
15936753
8.

Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.

Drolet R, Bélanger C, Fortier M, Huot C, Mailloux J, Légaré D, Tchernof A.

Obesity (Silver Spring). 2009 Mar;17(3):424-30. doi: 10.1038/oby.2008.555. Epub 2008 Dec 11.

PMID:
19219061
9.

Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells.

Perrini S, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, Caccioppoli C, Natalicchio A, Orlando MR, Garruti G, De Fazio M, Catalano G, Memeo V, Giorgino R, Giorgino F.

Diabetologia. 2008 Jan;51(1):155-64. Epub 2007 Oct 25.

PMID:
17960360
10.

Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes.

Harte AL, McTernan PG, McTernan CL, Smith SA, Barnett AH, Kumar S.

Diabetes Obes Metab. 2003 Sep;5(5):302-10.

PMID:
12940867
11.

Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.

Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lonnqvist F, Ferrannini E, Knuuti J, Nuutila P.

Diabetes Care. 2003 Jul;26(7):2069-74.

PMID:
12832315
12.

Mechanisms of metformin action on glucose transport and metabolism in human adipocytes.

Grisouard J, Timper K, Radimerski TM, Frey DM, Peterli R, Kola B, Korbonits M, Herrmann P, Krähenbühl S, Zulewski H, Keller U, Müller B, Christ-Crain M.

Biochem Pharmacol. 2010 Dec 1;80(11):1736-45. doi: 10.1016/j.bcp.2010.08.021. Epub 2010 Sep 8.

PMID:
20816671
13.

Sex difference in insulin-stimulated glucose transport in rat and human adipocytes.

Foley JE, Kashiwagi A, Chang H, Huecksteadt TP, Lillioja S, Verso MA, Reaven G.

Am J Physiol. 1984 Mar;246(3 Pt 1):E211-5.

PMID:
6367483
14.

Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.

Walker GE, Marzullo P, Verti B, Guzzaloni G, Maestrini S, Zurleni F, Liuzzi A, Di Blasio AM.

Obesity (Silver Spring). 2008 Sep;16(9):1983-91. doi: 10.1038/oby.2008.326.

PMID:
19186324
15.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
16.

Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.

Stolic M, Russell A, Hutley L, Fielding G, Hay J, MacDonald G, Whitehead J, Prins J.

Int J Obes Relat Metab Disord. 2002 Jan;26(1):17-23.

PMID:
11791142
17.

Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes.

Mueller WM, Stanhope KL, Gregoire F, Evans JL, Havel PJ.

Obes Res. 2000 Oct;8(7):530-9.

PMID:
11068959
18.

Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.

Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.

Diabetes Obes Metab. 2008 Jun;10(6):460-7. Epub 2007 Mar 29.

PMID:
17394563
19.

Impaired insulin action in subcutaneous adipocytes from women with visceral obesity.

Johnson JA, Fried SK, Pi-Sunyer FX, Albu JB.

Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E40-9.

20.

The relationship between fat depot-specific preadipocyte differentiation and metabolic syndrome in obese women.

Park HT, Lee ES, Cheon YP, Lee DR, Yang KS, Kim YT, Hur JY, Kim SH, Lee KW, Kim T.

Clin Endocrinol (Oxf). 2012 Jan;76(1):59-66. doi: 10.1111/j.1365-2265.2011.04141.x.

PMID:
21711372
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk